Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Hold
12,800
0.06% 231
2026
Q1
$1.19M Buy
+12,800
New +$1.13M 0.03% 338
2022
Q1
Sell
-7,200
Closed -$537K 572
2021
Q4
$537K Hold
7,200
0.02% 408
2021
Q3
$339K Sell
7,200
-400
-5% -$17.4K 0.01% 482
2021
Q2
$307K Sell
7,600
-900
-11% -$37.3K 0.01% 503
2021
Q1
$349K Buy
+8,500
New +$317K 0.01% 446
2020
Q3
Sell
-8,626
Closed -$240K 513
2020
Q2
$240K Buy
+8,626
New +$210K 0.01% 456
2020
Q1
Sell
-8,500
Closed -$205K 478
2019
Q4
$205K Buy
+8,500
New +$179K 0.01% 498

Other funds holding ACLS

WesBanco Bank's ACLS Position: Q2 2026 in Review

WesBanco Bank held its Axcelis (ACLS) position steady in Q2 2026 at 12,800 shares worth $2.42M. The position accounts for 0.06% of the portfolio, ranked #231.

WesBanco Bank first reported a position in ACLS in Q4 2019 and has held it in 8 quarters since. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • WesBanco Bank held 12,800 shares of Axcelis worth $2.42M as of Q2 2026.
  • WesBanco Bank left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up 0.06% of WesBanco Bank's portfolio in Q2 2026, its #231 holding.
  • WesBanco Bank first reported a position in Axcelis in Q4 2019 and has held it in 8 quarters since.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.